Patents by Inventor Jen-Wei Wang

Jen-Wei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases
    Patent number: 11447778
    Abstract: Nucleic acid aptamers that bind to tumor necrosis factor alpha (TNF). Also provided herein are pharmaceutical compositions comprising such anti-TNF aptamers and methods for the using the same for therapeutic and diagnostic applications, for example, alleviating liver injury and monitoring presence of TNF in vivo or in vitro.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: September 20, 2022
    Assignees: Academia Sinica, National Taiwan University
    Inventors: Pan-Chyr Yang, Wei-Yun Lai, Jen-Wei Wang
  • TNF-TARGETING APTAMERS AND USES THEREOF FOR TREATMENT OR DIAGNOSING TNF-RELATED INFLAMMATORY DISEASES
    Publication number: 20210254072
    Abstract: Nucleic acid aptamers that bind to tumor necrosis factor alpha (TNF). Also provided herein are pharmaceutical compositions comprising such anti-TNF aptamers and methods for the using the same for therapeutic and diagnostic applications, for example, alleviating liver injury and monitoring presence of TNF in vivo or in vitro.
    Type: Application
    Filed: December 21, 2018
    Publication date: August 19, 2021
    Inventors: Pan-Chyr Yang, Wei-Yun Lai, Jen-Wei Wang